- Home
- SOTK vs NRSN Comparison
SOTK vs NRSN Comparison
Compare SOTK & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOTK
- NRSN
- Stock Information
- Founded
- SOTK 1975
- NRSN 2017
- Country
- SOTK United States
- NRSN Israel
- Employees
- SOTK 89
- NRSN N/A
- Industry
- SOTK Industrial Machinery/Components
- NRSN Biotechnology: Pharmaceutical Preparations
- Sector
- SOTK Technology
- NRSN Health Care
- Exchange
- SOTK Nasdaq
- NRSN Nasdaq
- Market Cap
- SOTK 52.1M
- NRSN 50.1M
- IPO Year
- SOTK 1987
- NRSN 2021
- Fundamental
- Price
- SOTK $3.31
- NRSN $1.08
- Analyst Decision
- SOTK Hold
- NRSN Buy
- Analyst Count
- SOTK 1
- NRSN 2
- Target Price
- SOTK N/A
- NRSN $14.00
- AVG Volume (30 Days)
- SOTK 7.9K
- NRSN 315.6K
- Earning Date
- SOTK 07-10-2025
- NRSN 09-29-2025
- Dividend Yield
- SOTK N/A
- NRSN N/A
- EPS Growth
- SOTK N/A
- NRSN N/A
- EPS
- SOTK 0.09
- NRSN N/A
- Revenue
- SOTK $20,606,116.00
- NRSN N/A
- Revenue This Year
- SOTK N/A
- NRSN N/A
- Revenue Next Year
- SOTK $7.13
- NRSN N/A
- P/E Ratio
- SOTK $36.78
- NRSN N/A
- Revenue Growth
- SOTK N/A
- NRSN N/A
- 52 Week Low
- SOTK $3.25
- NRSN $0.60
- 52 Week High
- SOTK $6.05
- NRSN $2.60
- Technical
- Relative Strength Index (RSI)
- SOTK 33.85
- NRSN 22.62
- Support Level
- SOTK $3.25
- NRSN $1.69
- Resistance Level
- SOTK $3.72
- NRSN $2.09
- Average True Range (ATR)
- SOTK 0.09
- NRSN 0.19
- MACD
- SOTK -0.02
- NRSN -0.08
- Stochastic Oscillator
- SOTK 12.77
- NRSN 7.27
About SOTK Sono-Tek Corporation
Sono-Tek Corp design and manufacture of ultrasonic coating systems for applying precise, thin film coatings to add functional properties, protect or strengthen surfaces on parts and components for the microelectronics/electronics, alternative energy, medical, industrial and emerging research & development/other markets. The company design and manufacture custom-engineered ultrasonic coating systems incorporating its patented technology, in combination with strong applications engineering knowledge, to assist its customers in achieving their desired coating solutions.
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.